Nuclear hormone receptors: From molecules to diseases

Journal of Investigative Medicine

Volumn 47, Issue 8, 1999, Pages 364-368

  Lazar, Mitchell A ^a,b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR;

CELL NUCLEUS; GENETICS; HUMAN; METABOLISM; MITOSIS; MUTATION; MYELOID LEUKEMIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

CELL NUCLEUS; DIABETES MELLITUS, TYPE 2; HUMANS; LEUKEMIA, MYELOID; MITOSIS; MUTATION; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION;

EID: 0033192988     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, et al. The nuclear receptor superfamily: the second decade. Cell 1995;83:835-9.
2. Enmark E, Gustafsson J-A. Orphan nuclear receptors - the first eight years. Mol Endocrinol 1996;10:1293-307.
3. Lazar MA. Thyroid hormone receptors: multiple forms, multiple possibilities. Endocrine Rev 1993;14:184-93.
4. Melnick A, Licht ID. Deconstructing a disease: RARα, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 1999;93:3167-215.
5. He LZ, Guidez F, Tribioli C, Peruzzi D, Ruthardt M, Zelent A, Pandolfi PP. Distinct interactions of PML-RARα and PLZF-RARα with co-repressors determine differential responses to RA in APL. Nat Genet 1998;18:126-35.
6. Grignani F, DeMatteis S, Nervi C, Tomassom L, Gelmetti V, Cioce M, Fanelli M, Ruthardt M, Ferrara FF, Zamir I. Fusion proteins of the retinoic acid receptor-α recruit histone deacetylase in promyelocytic leukemia. Nature 1998;391:815-8.
7. Lin RJ, Nagy L, Inoue S, Shao W, Miller WH, Evans RM. Role of the histone deacetylase complex in acute promyelocytic leukemia. Nature 1998;391:811-4.
8. Hong SH, David G, Wong CW, Dejean A, Privalsky ML. SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor a and PLZF-RARα oncoproteins associated with acute promyelocytic leukemia. Proc Natl Acad Sci USA 1997;94:9028-33.
9. Wang J, Hoshino T, Redner RL, Kajigaya S, Liu JM. ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex. Proc Natl Acad Sci USA 1998;95:10860-5.
10. Lutterbach B, Westendorf JJ, Linggi B, Patten A, Moniwa M, Davie JR, Huynh KD, Bardwell VJ, Lavinsky RM, Rosenfeld MG, et al. ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors. Mol Cell Biol 1998;18:7176-84.
11. Gelmetti V, Zhang J, Fanelli M, Minucci S, Pelicci PG, Lazar MA. Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO. Mol Cell Biol 1998;18:7185-91.
12. Henry RR. Thiazolidinediones. Endocrinol Metab Clin North Am 1997;26:553-73.
13. Kletzien RF, Clarke SD, Ulrich RG. Enhancement of adipocyte differentiation by an insulin-sensitizing agent. Mol Pharmacol 1992;41:393-8.
14. Chawla A, Lazar MA. Peroxisome proliferator and retinoid signaling pathways coregulate preadipocyte phenotype and survival. Proc Natl Acad Sci USA 1994;91:1786-90.
15. Chawla A, Schwarz EJ, Dimaculangan DD, Lazar MA. Peroxisome proliferator-activated receptor γ (PPARγ): adipose predominant expression and induction early in adipocyte differentiation. Endocrinology 1994;135:798-800.
16. Tontonoz P, Hu E, Graves RA, Budavari AI, Spiegelman BM. mPPARγ2: tissue-specific regulator of an adipocyte enhancer. Genes Dev 1994;8:1224-34.
17. Tontonoz P, Hu E, Devine J, Beale KG, Spiegelman BM. PPAR gamma 2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene. Mol Cell Biol 1995;15:351-7.
18. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA. An antidiabetic thiazolidinedione is a high affinity ligand for the nuclear peroxisome proliferator-activated receptor γ (PPARγ). J Biol Chem 1995;270:12953-6.
19. Reginato MJ, Bailey ST, Krakow SL, Minami C, Ishii S, Takaka H. A potent antidiabetic thiazolidinedione with unusual PPARγ-activating properties. J Biol Chem 1998;273:32679-84.
20. Shibata H, Spencer TE, Onate SA, Jenster G, Tsai SY, Tsai MJ, O'Malley BW. Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action. Recent Prog Horm Res 1997;52:141-64.
21. Casini T, Grignani F, Pelicci PG. Genetics of APL and the molecular basis of retinoic acid treatment. Int J Cancer 1997;70:473-4.